Cargando…

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Arnon, Tal I., Markel, Gal, Bar-Ilan, Ahuva, Hanna, Jacob, Fima, Eyal, Benchetrit, Fabrice, Galili, Ruth, Cerwenka, Adelheid, Benharroch, Daniel, Sion-Vardy, Netta, Porgador, Angel, Mandelboim, Ofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418968/ https://www.ncbi.nlm.nih.gov/pubmed/25938552 http://dx.doi.org/10.1371/journal.pone.0128052

Ejemplares similares

Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

CD100 on NK Cells Enhance IFNγ Secretion and Killing of Target Cells Expressing CD72
por: Mizrahi, Sa'ar, et al.
Publicado: (2007)

NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy
por: Garcés-Lázaro, Irene, et al.
Publicado: (2022)

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
por: Yossef, Rami, et al.
Publicado: (2015)

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
por: Pahl, Jens H. W., et al.
Publicado: (2018)

Toward the next generation of NK cell-based adoptive cancer immunotherapy
por: Ni, Jing, et al.
Publicado: (2013)

HMGB1: The metabolic weapon in the arsenal of NK cells
por: Cerwenka, Adelheid, et al.
Publicado: (2016)

Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity
por: Glasner, Ariella, et al.
Publicado: (2015)

NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
por: Ghadially, Hormas, et al.
Publicado: (2014)

Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
por: Ni, Jing, et al.
Publicado: (2012)

Memory of Infections: An Emerging Role for Natural Killer Cells
por: Rölle, Alexander, et al.
Publicado: (2013)

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity
por: Duev-Cohen, Alexandra, et al.
Publicado: (2016)

Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)

Harnessing NK Cells to Control Metastasis
por: Deng, Xuewen, et al.
Publicado: (2022)

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
por: Markel, Gal, et al.
Publicado: (2009)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Hepatitis C Virus and Human Cytomegalovirus—Natural Killer Cell Subsets in Persistent Viral Infections
por: Pollmann, Julia, et al.
Publicado: (2017)

Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
por: Giannattasio, Ariane, et al.
Publicado: (2015)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
por: Routes, John M., et al.
Publicado: (2005)

PILRα binds an unknown receptor expressed primarily on CD56(bright) and decidual-NK cells and activates NK cell functions
por: Ophir, Yael, et al.
Publicado: (2016)

Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
por: Kotzur, Rebecca, et al.
Publicado: (2023)

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
por: Glasner, Ariella, et al.
Publicado: (2017)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
por: Shin, Eunju, et al.
Publicado: (2023)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
por: Granzin, Markus, et al.
Publicado: (2017)

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D
por: Diab, Mohammad, et al.
Publicado: (2020)

A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors
por: Floerchinger, Alessia, et al.
Publicado: (2023)

Harnessing Memory NK Cell to Protect Against COVID-19
por: Soleimanian, Saeede, et al.
Publicado: (2020)

NK-92 cells retain vitality and functionality when grown in standard cell culture conditions
por: Kotzur, Rebecca, et al.
Publicado: (2022)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors
por: Yamin, Rachel, et al.
Publicado: (2013)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

HSV-2 Specifically Down Regulates HLA-C Expression to Render HSV-2-Infected DCs Susceptible to NK Cell Killing
por: Elboim, Moran, et al.
Publicado: (2013)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022)

Carbohydrate-Mediated Modulation of NK Cell Receptor Function: Structural and Functional Influences of Heparan Sulfate Moieties Expressed on NK Cell Surface
por: Brusilovsky, Michael, et al.
Publicado: (2014)

Novel Alzheimer’s disease subtypes identified using a data and knowledge driven strategy
por: Mitelpunkt, Alexis, et al.
Publicado: (2020)

Cytokine secretion and NK cell activity in human ADAM17 deficiency
por: Tsukerman, Pinchas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nr48m02qlljnu60bvnk30je6rd